157 related articles for article (PubMed ID: 23558042)
1. Role of C-reactive protein in determining microvascular function in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention.
Sezer M; Akdeniz C; Aslanger E; Kaplan A; Yilmaz A; Guz G; Umman B; Bugra Z; Umman S
Am J Cardiol; 2013 Jun; 111(12):1734-8. PubMed ID: 23558042
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous coronary intervention increases microvascular resistance in patients with non-ST-elevation acute coronary syndrome.
Akdeniz C; Umman S; Nisanci Y; Umman B; Bugra Z; Aslanger EK; Kaplan A; Yilmaz A; Teker E; Güz G; Polat N; Sezer M
EuroIntervention; 2013 Jun; 9(2):228-34. PubMed ID: 23410633
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein elevation and rapid angiographic progression of nonculprit lesion in patients with non-ST-segment elevation acute coronary syndrome.
Nakachi T; Kosuge M; Hibi K; Ebina T; Hashiba K; Mitsuhashi T; Endo M; Umemura S; Kimura K
Circ J; 2008 Dec; 72(12):1953-9. PubMed ID: 18957790
[TBL] [Abstract][Full Text] [Related]
4. Correlation of platelet reactivity and C-reactive protein levels to occurrence of peri-procedural myocardial infarction in patients undergoing percutaneous coronary intervention (from the ARMYDA-CRP study).
Patti G; Mangiacapra F; Ricottini E; Cannatà A; Cavallari I; Vizzi V; D'Ambrosio A; Dicuonzo G; Di Sciascio G
Am J Cardiol; 2013 Jun; 111(12):1739-44. PubMed ID: 23538022
[TBL] [Abstract][Full Text] [Related]
5. Association between angiographic complications and clinical outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention: an EARLY ACS (Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndrome) angiographic substudy.
Pride YB; Mohanavelu S; Zorkun C; Kunadian V; Giugliano RP; Newby LK; Braunwald E; Califf RM; Harrington RA; Gibson CM;
JACC Cardiovasc Interv; 2012 Sep; 5(9):927-35. PubMed ID: 22995880
[TBL] [Abstract][Full Text] [Related]
6. Early electrocardiographic findings and MR imaging-verified microvascular injury and myocardial infarct size.
Nijveldt R; van der Vleuten PA; Hirsch A; Beek AM; Tio RA; Tijssen JG; Piek JJ; van Rossum AC; Zijlstra F
JACC Cardiovasc Imaging; 2009 Oct; 2(10):1187-94. PubMed ID: 19833308
[TBL] [Abstract][Full Text] [Related]
7. Angiographic outcomes in the PLATO Trial (Platelet Inhibition and Patient Outcomes).
Kunadian V; James SK; Wojdyla DM; Zorkun C; Wu J; Storey RF; Steg PG; Katus H; Emanuelsson H; Horrow J; Maya J; Wallentin L; Harrington RA; Gibson CM
JACC Cardiovasc Interv; 2013 Jul; 6(7):671-83. PubMed ID: 23866179
[TBL] [Abstract][Full Text] [Related]
8. Pre-percutaneous Coronary Intervention Pericoronary Adipose Tissue Attenuation Evaluated by Computed Tomography Predicts Global Coronary Flow Reserve After Urgent Revascularization in Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome.
Kanaji Y; Hirano H; Sugiyama T; Hoshino M; Horie T; Misawa T; Nogami K; Ueno H; Hada M; Yamaguchi M; Sumino Y; Hamaya R; Usui E; Yonetsu T; Sasano T; Kakuta T
J Am Heart Assoc; 2020 Sep; 9(17):e016504. PubMed ID: 32856503
[TBL] [Abstract][Full Text] [Related]
9. The effect of lipid and inflammatory profiles on the morphological changes of lipid-rich plaques in patients with non-ST-segment elevated acute coronary syndrome: follow-up study by optical coherence tomography and intravascular ultrasound.
Takarada S; Imanishi T; Ishibashi K; Tanimoto T; Komukai K; Ino Y; Kitabata H; Kubo T; Tanaka A; Kimura K; Mizukoshi M; Akasaka T
JACC Cardiovasc Interv; 2010 Jul; 3(7):766-72. PubMed ID: 20650439
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic value of plasma brain natriuretic peptide and C-reactive protein in patients with acute coronary syndromes underwent percutaneous coronary intervention].
He B; Ding S; Pu J; Liu JP; Song W; Du YP; Shen JY; Jin SX; Sun Y; Shen L
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):349-52. PubMed ID: 16776932
[TBL] [Abstract][Full Text] [Related]
11. An early and simple predictor of severe left main and/or three-vessel disease in patients with non-ST-segment elevation acute coronary syndrome.
Kosuge M; Ebina T; Hibi K; Morita S; Endo M; Maejima N; Iwahashi N; Okada K; Ishikawa T; Umemura S; Kimura K
Am J Cardiol; 2011 Feb; 107(4):495-500. PubMed ID: 21184992
[TBL] [Abstract][Full Text] [Related]
12. Relation of leukocytosis to C-reactive protein and interleukin-6 among patients undergoing percutaneous coronary intervention.
Gogo PB; Schneider DJ; Terrien EF; Watkins MW; Sobel BE; Dauerman HL
Am J Cardiol; 2005 Aug; 96(4):538-42. PubMed ID: 16098308
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) trial.
Palmerini T; Genereux P; Caixeta A; Cristea E; Lansky A; Mehran R; Dangas G; Lazar D; Sanchez R; Fahy M; Xu K; Stone GW
J Am Coll Cardiol; 2011 Jun; 57(24):2389-97. PubMed ID: 21658558
[TBL] [Abstract][Full Text] [Related]
14. Attenuated plaque detected by intravascular ultrasound: clinical, angiographic, and morphologic features and post-percutaneous coronary intervention complications in patients with acute coronary syndromes.
Lee SY; Mintz GS; Kim SY; Hong YJ; Kim SW; Okabe T; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R; Weissman NJ
JACC Cardiovasc Interv; 2009 Jan; 2(1):65-72. PubMed ID: 19463400
[TBL] [Abstract][Full Text] [Related]
15. Changes in C-reactive protein levels following coronary stent implantation depend on the extent of periprocedural arterial injury.
Kralisz P; Kemona H; Dobrzycki S; Bachórzewska-Gajewska H; Nowak K; Sawicki Z
Kardiol Pol; 2006 Apr; 64(4):364-71; discussion 372. PubMed ID: 16699978
[TBL] [Abstract][Full Text] [Related]
16. Intensive Statin Therapy in NSTE-ACS Patients Undergoing PCI: Clinical and Biochemical Effects.
Shehata M; Fayez G; Nassar A
Tex Heart Inst J; 2015 Dec; 42(6):528-36. PubMed ID: 26664304
[TBL] [Abstract][Full Text] [Related]
17. Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in female patients with non-ST-segment elevation acute coronary syndrome.
Gao Y; Jia ZM; Sun YJ; Zhang ZH; Ren LN; Qi GX
Chin Med J (Engl); 2012 Jul; 125(13):2250-4. PubMed ID: 22882843
[TBL] [Abstract][Full Text] [Related]
18. Effect of a single high loading dose of rosuvastatin on percutaneous coronary intervention for acute coronary syndromes.
Wang Z; Dai H; Xing M; Yu Z; Lin X; Wang S; Zhang J; Hou F; Ma Y; Ren Y; Tan K; Wang Y; Ge Z
J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):327-33. PubMed ID: 23364255
[TBL] [Abstract][Full Text] [Related]
19. Response of high-sensitivity C-reactive protein to percutaneous coronary intervention in patients with acute coronary syndrome.
Yun KH; Jeong MH; Oh SK; Rhee SJ; Park EM; Lee EM; Yoo NJ; Kim NH; Ahn YK; Jeong JW
Heart Vessels; 2009 May; 24(3):175-80. PubMed ID: 19466517
[TBL] [Abstract][Full Text] [Related]
20. Coronary microvascular resistance index immediately after primary percutaneous coronary intervention as a predictor of the transmural extent of infarction in patients with ST-segment elevation anterior acute myocardial infarction.
Kitabata H; Imanishi T; Kubo T; Takarada S; Kashiwagi M; Matsumoto H; Tsujioka H; Ikejima H; Arita Y; Okochi K; Kuroi A; Ueno S; Kataiwa H; Tanimoto T; Yamano T; Hirata K; Nakamura N; Tanaka A; Mizukoshi M; Akasaka T
JACC Cardiovasc Imaging; 2009 Mar; 2(3):263-72. PubMed ID: 19356570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
